Novo and Lilly have invested billions to ramp up supply of their treatments, which lagged demand for most of last year
Studies have found that those using Semaglutide GLP-1 lost up to 10% of their body weight over a period of 16 weeks, compared to those not using Semaglutide GLP-1, who lost an average of 3%
"I think, for me, GLP-1s are a lifetime thing
Results are gradual and tied to consistent use, often paired with lifestyle adjustments
With our solution, each meal triggers the release of a hormone that signals satisfaction, replicating the feeling of fullness
Canadian 24-hour movement guidelines for adults aged 18-64 years and adults aged 65 years or older: an integration of physical activity, sedentary behaviour, and sleep